These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3225942)

  • 1. [Natural killer (NK) activity and NK subsets in patients with inflammatory bowel disease].
    Hayashi K; Hirata I; Orino S; Saitoh O; Fujita T; Okumura Y; Ashida K; Miyoshi H; Asada S; Ohshiba S
    Nihon Shokakibyo Gakkai Zasshi; 1988 Jun; 85(6):1240-4. PubMed ID: 3225942
    [No Abstract]   [Full Text] [Related]  

  • 2. [Natural killer cells in inflammatory diseases of the large intestine].
    Khalif IL; Bakhov NI; Kirkin BV; Osipov SG; Mikhaĭlova TL
    Sov Med; 1986; (4):32-4. PubMed ID: 3715605
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
    Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
    J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
    Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM
    Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis.
    Aparicio-Pagés MN; Verspaget HW; Peña AS; Weterman IT; Mieremet-Ooms MA; van der Zon JM; de Bruin PA; Lamers CB
    J Clin Lab Immunol; 1988 Nov; 27(3):109-13. PubMed ID: 3246686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity.
    Gibson PR; Jewell DP
    Gastroenterology; 1986 Jan; 90(1):12-9. PubMed ID: 3509998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
    Kusugami K; Youngman KR; West GA; Fiocchi C
    Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammatory bowel disease; etiology and progress of immunological studies].
    Yachi A; Sugiyama T
    Nihon Rinsho; 1988 Feb; 46(2):276-82. PubMed ID: 3259990
    [No Abstract]   [Full Text] [Related]  

  • 9. Intestinal lymphokine-activated killer cells in inflammatory bowel disease.
    Hogan PG; Gibson PR; Hapel AJ; Doe WF
    J Gastroenterol Hepatol; 1991; 6(5):455-60. PubMed ID: 1932665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.
    Manzano L; Alvarez-Mon M; Abreu L; Antonio Vargas J; de la Morena E; Corugedo F; Duràntez A
    Gut; 1992 Feb; 33(2):246-51. PubMed ID: 1541421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
    Brown TE; Bankhurst AD; Strickland RG
    J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.
    Shanahan F; Leman B; Deem R; Niederlehner A; Brogan M; Targan S
    J Clin Immunol; 1989 Jan; 9(1):55-64. PubMed ID: 2522935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.
    Fuss IJ; Heller F; Boirivant M; Leon F; Yoshida M; Fichtner-Feigl S; Yang Z; Exley M; Kitani A; Blumberg RS; Mannon P; Strober W
    J Clin Invest; 2004 May; 113(10):1490-7. PubMed ID: 15146247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity in patients with inflammatory bowel disease.
    Egawa S; Hiwatashi N
    J Clin Lab Immunol; 1986 Aug; 20(4):187-92. PubMed ID: 3093683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
    Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
    Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of serum 2-5AS activity and NK cell activity in the patients with Crohn's disease and ulcerative colitis].
    Suzuki H; Sata M; Yano Y; Kamoi S; Ikeda H; Sasaki E; Toyonaga A; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1988 Jan; 85(1):14-9. PubMed ID: 3373766
    [No Abstract]   [Full Text] [Related]  

  • 17. Distal procto-colitis, natural cytotoxicity, and essential fatty acids.
    Almallah YZ; Richardson S; O'Hanrahan T; Mowat NA; Brunt PW; Sinclair TS; Ewen S; Heys SD; Eremin O
    Am J Gastroenterol; 1998 May; 93(5):804-9. PubMed ID: 9625132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease.
    Gibson PR; van de Pol E; Pullman W; Doe WF
    Gut; 1988 Aug; 29(8):1076-84. PubMed ID: 3261705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.
    Aparicio-Pagés MN; Verspaget HW; Hafkenscheid JC; Crama-Bohbouth GE; Peña AS; Weterman IT; Lamers HW
    Gut; 1990 Sep; 31(9):1030-2. PubMed ID: 1976576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies on Crohn's disease. III. Defective natural killer activity.
    Okabe N; Fujita K; Yao T
    J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.